Gresnigt, Mark S <br/><br/>
Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor.  [electronic resource] 

 -  Scientific reports  05 2016 
 - 26490 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep26490  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--adverse effects<br/>Animals<br/>Carbonic Anhydrase IX--metabolism<br/>Cell Hypoxia--drug effects<br/>Cytokines--metabolism<br/>Disease Models, Animal<br/>Immunocompromised Host<br/>Interleukin 1 Receptor Antagonist Protein--administration & dosage<br/>Invasive Pulmonary Aspergillosis--drug therapy<br/>Mice<br/>Receptors, Interleukin-1--antagonists & inhibitors<br/>Receptors, Interleukin-8B--deficiency<br/>Treatment Outcome